Chloroquine as a steroid sparing agent for asthma

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 4, 2003, Pages

  Dewey, Ann ^a   Bara, Anna ^b   Lasserson, Toby J ^c   Walters, E Haydn ^d  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b Medical Unit   (United Kingdom)

^c The Cochrane Collaboration   (United Kingdom)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58149292061     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003275     Document Type: Review

References (15)

1. Roberts JA, Gunneberg A, Elliott JA, Thomson NC. Hydroxychloroquine in steroid dependent asthma. Pulmonary Pharmacology 1988;1:59-61.
2. Charous BL. Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma. Annals of Allergy 1990;65:53-8.
3. Charous BL. Effectiveness of long-term treatment of severe asthma with hydroxychloroquine (HCQ). Annals of NY Academy of Sciences 1991;629:432-3.
4. Hiragi. Novel treatment for bronchial asthma. Sego Rynsko 1964;13(1):152-7.
5. Isomaki H, Kreus KE. Chloroquine in the treatment of bronchial asthma. Annals of Allergy 1968;26:61-5.
6. Spector SL. Alternative treatments in the patient with intractable asthma. Pulmonary Medicine 1997;3:23-9.
7. Stern A, Zucker A, Sherman W, Florio A. An investigation into the use of aralen in bronchial asthma. Annals of Allergy 1960;18:980-2.
8. Tennenbaum JI, Smith RE. Antimalarial therapy for resistant asthma. Annals of Allergy 1966;24:37-40.
9. Adams NP, Bestall JC, Lasserson TJ, Jones P, Cates CJ. Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD003135.pub4]
10. Charous BL, Halpern EF, Stevens GC. Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma. Journal of Allergy & Clnical Immunology 1998;102:198-203.
11. Evans DJ, Cullinan P, Geddes DM, Walters EH, Jones PW. Gold as an oral steroid sparing agent for asthma. Cochrane Database of Systematic Reviews 2000, Issue 4. [DOI: 10.1002/14651858.CD002985]
12. Goldstein JA. Hydroxychloroquine for asthma (letter). American Review of Respiratory Disease 1983;128:1100-1.
13. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
14. Ruhl R, Halpern GM, Gershwin ME. Unconventional approaches to drug therapy in severe asthma. Allergologia et Immunopathologia 1993;21(2):53-60.
15. Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH. Anti-IgE for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD003559.pub3]